Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (9641)	8/16/2006 4:36:06 PM
From: ritzkid8	Read Replies (1) \| Respond to of 10280

Would you really want to buy Sepracor at $40? IMHO, if the stock breaks through what little technical support it has in the mid $40's, it will probably fall to $40 or below and stay there for a while. Without a buyout, this company has to prove to investors that it can execute and deliver earnings that will support a higher valuation. Flat sales, high expenses, the Xopenex patent challenge and the stock options investigation are all putting pressure on this stock to the downside. I hope they can fix things and get it turned around because I still own shares in the company. But I am losing confidence this will happen before it's too late.